Back

Serial changes in left atrial strain in symptomatic obstructive hypertrophic cardiomyopathy treated with mavacamten: insights from VALOR-HCM trial

2 September 2024 (14:03 - 14:22)
Organised by: Logo
Congress Presentation Part of: New imaging insights into hypertrophic cardiomyopathy Tissue Doppler, Speckle Tracking and Strain Imaging ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Milind Desai

Cleveland Clinic, Cleveland (United States of America)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on hypertrophic cardiomyopathy
Professor C. Manisty (London, GB)
Slides Video
Presentation thumbnail
Comparison of mitral valve apparatus anomalies between sarcomeric hypertrophic cardiomyopathy and Fabry disease cardiomyopathy
Doctor P. D'Andria (Milano, IT)
Abstract Slides Video
Presentation thumbnail
How different types of cardiomyopathy with hypertrophic phenotype affect left atrial remodeling and function
Doctor M. De Raffele (Ferrara, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New imaging insights into hypertrophic cardiomyopathy
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 14:03 CET
You may be interested in
thumbnail
Congress Presentation
Serial changes in left and right ventricular global longitudinal strain in symptomatic obstructive hypertrophic cardiomyopathy treated with mavacamten: insights from VALOR-HCM trial
thumbnail
Congress Presentation
Echocardiographic changes in nonobstructive hypertrophic cardiomyopathy patients treated with mavacamten: A sub-study of the ODYSSEY-HCM trial
thumbnail
Congress Session
Cardiac myosin inhibitors for treatment of hypertrophic obstructive cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources